ENTHEON BIOMEDICAL CORP
ENTHEON BIOMEDICAL CORP
Share · CA29383X1033 · A2QJBZ (XCNQ)
Overview
No Price
Closing Price XCNQ 28.10.2025: 0,10 CAD
28.10.2025 19:03
Current Prices from ENTHEON BIOMEDICAL CORP
ExchangeTickerCurrencyLast TradePriceDaily Change
XCNQ: CSE LISTED
CSE LISTED
ENBI.CN
CAD
28.10.2025 14:15
0,10 CAD
0,00 CAD
Share Float & Liquidity
Free Float 97,98 %
Shares Float 13,58 M
Shares Outstanding 13,86 M
Company Profile for ENTHEON BIOMEDICAL CORP Share
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Get up to date insights from finAgent about ENTHEON BIOMEDICAL CORP

Company Data

Name ENTHEON BIOMEDICAL CORP
Company Entheon Biomedical Corp.
Website https://www.entheonbiomedical.com
Primary Exchange XCNQ CSE LISTED
WKN A2QJBZ
ISIN CA29383X1033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Timothy Ko
Country Canada
Currency EUR
Employees 0,0 T
Address 999 West Broadway, V5Z 1K5 Vancouver
IPO Date 2018-05-03

Ticker Symbols

Name Symbol
CSE LISTED ENBI.CN
More Shares
Investors who hold ENTHEON BIOMEDICAL CORP also have the following shares in their portfolio:
ALSTRIA OFFICE REIT-AG
ALSTRIA OFFICE REIT-AG Share
CITI TRENDS INC
CITI TRENDS INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025